Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gene replacement ameliorates deficits in mouse and human models of cyclin-dependent kinase-like 5 disorder
Yunan Gao, Elaine E. Irvine, Ioanna Eleftheriadou, et al.
Brain (2020) Vol. 143, Iss. 3, pp. 811-832
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

AAV-based in vivo gene therapy for neurological disorders
Qinglan Ling, Jessica A. Herstine, Allison M. Bradbury, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 10, pp. 789-806
Closed Access | Times Cited: 89
CDKL5 deficiency disorder: clinical features, diagnosis, and management
Helen Leonard, Jenny Downs, Tim A. Benke, et al.
The Lancet Neurology (2022) Vol. 21, Iss. 6, pp. 563-576
Open Access | Times Cited: 88
Altered motor learning and coordination in mouse models of autism spectrum disorder
Katherine R. Cording, Helen S. Bateup
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 29
Recent advances in gene therapy for neurodevelopmental disorders with epilepsy
Thomas J. Turner, Clara Zourray, Stéphanie Schorge, et al.
Journal of Neurochemistry (2020) Vol. 157, Iss. 2, pp. 229-262
Open Access | Times Cited: 51
Temporal manipulation of Cdkl5 reveals essential postdevelopmental functions and reversible CDKL5 deficiency disorder–related deficits
Barbara Terzic, M. Felicia Davatolhagh, Yugong Ho, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 20
Open Access | Times Cited: 48
Cell type-specific expression, regulation and compensation of CDKL5 activity in mouse brain
Margaux Silvestre, Kelvin Dempster, Simeon R. Mihaylov, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 6, pp. 1844-1856
Open Access | Times Cited: 8
The expanding field of genetic developmental and epileptic encephalopathies: current understanding and future perspectives
Nicola Specchio, Marina Trivisano, Eleonora Aronica, et al.
The Lancet Child & Adolescent Health (2024) Vol. 8, Iss. 11, pp. 821-834
Closed Access | Times Cited: 6
Early-Onset Developmental and Epileptic Encephalopathies of Infancy: An Overview of the Genetic Basis and Clinical Features
Nadine Morrison‐Levy, Felippe Borlot, Puneet Jain, et al.
Pediatric Neurology (2020) Vol. 116, pp. 85-94
Closed Access | Times Cited: 44
Current neurologic treatment and emerging therapies in CDKL5 deficiency disorder
Heather E. Olson, Carolyn I. Daniels, Isabel Haviland, et al.
Journal of Neurodevelopmental Disorders (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 35
A Review of Targeted Therapies for Monogenic Epilepsy Syndromes
Vincent Zimmern, Berge A. Minassian, Christian Korff
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 27
CDKL5 Deficiency Disorder-Related Epilepsy: A Review of Current and Emerging Treatment
William Hong, Isabel Haviland, Elia M. Pestana-Knight, et al.
CNS Drugs (2022) Vol. 36, Iss. 6, pp. 591-604
Open Access | Times Cited: 24
Are Genetic Therapies for Epilepsy Ready for the Clinic?
James S. Street, Yichen Qiu, Gabriele Lignani
Epiliepsy currents/Epilepsy currents (2023) Vol. 23, Iss. 4, pp. 245-250
Open Access | Times Cited: 13
Touchscreen cognitive deficits, hyperexcitability and hyperactivity in males and females using two models ofCdkl5deficiency
Anna Adhikari, Fiona K B Buchanan, Timothy A. Fenton, et al.
Human Molecular Genetics (2022) Vol. 31, Iss. 18, pp. 3032-3050
Open Access | Times Cited: 20
CDKL5 sculpts functional callosal connectivity to promote cognitive flexibility
Patricia N. Awad, Valerio Zerbi, Erin Johnson‐Venkatesh, et al.
Molecular Psychiatry (2023) Vol. 29, Iss. 6, pp. 1698-1709
Open Access | Times Cited: 12
Comparison of evoked potentials across four related developmental encephalopathies
Joni N. Saby, Sarika U. Peters, Tim A. Benke, et al.
Journal of Neurodevelopmental Disorders (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 12
Discovery and characterization of a specific inhibitor of serine-threonine kinase cyclin-dependent kinase-like 5 (CDKL5) demonstrates role in hippocampal CA1 physiology
Anna Castano, Margaux Silvestre, Carrow I. Wells, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 12
Variable expression of MECP2, CDKL5, and FMR1 in the human brain: Implications for gene restorative therapies
Antonino Zito, Jeannie T. Lee
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 9
Open Access | Times Cited: 4
Recent advances and current status of gene therapy for epilepsy
Aojie Cai, Kai Gao, Fan Zhang, et al.
World Journal of Pediatrics (2024) Vol. 20, Iss. 11, pp. 1115-1137
Closed Access | Times Cited: 4
Clinical trials for Lennox–Gastaut syndrome: Challenges and priorities
Juliet K. Knowles, Aaron E. L. Warren, Ismail Mohamed, et al.
Annals of Clinical and Translational Neurology (2024) Vol. 11, Iss. 11, pp. 2818-2835
Open Access | Times Cited: 4
Independent genetic strategies define the scope and limits of CDKL5 deficiency disorder reversal
Xi-E Song, Zijie Xia, Dayne Martinez, et al.
Cell Reports Medicine (2025), pp. 101926-101926
Open Access
Navigating Uncertainty: Assessing Variants of Uncertain Significance in the CDKL5 Gene for Developmental and Epileptic Encephalopathy Using In Silico Prediction Tools and Computational Analysis
Özlem Yalçın Çapan
Journal of Molecular Neuroscience (2025) Vol. 75, Iss. 1
Closed Access
Electrophysiological biomarkers of brain function in CDKL5 deficiency disorder
Joni N. Saby, Patrick J. Mulcahey, Alexis Zavez, et al.
Brain Communications (2022) Vol. 4, Iss. 4
Open Access | Times Cited: 17
Preclinical studies of gene replacement therapy for CDKL5 deficiency disorder
Gregory Voronin, Jana Narasimhan, Jamila Gittens, et al.
Molecular Therapy (2024) Vol. 32, Iss. 10, pp. 3331-3345
Closed Access | Times Cited: 3
Experimental Models to Study Autism Spectrum Disorders: hiPSCs, Rodents and Zebrafish
Alba Pensado‐López, Sara Veiga-Rúa, Ángel Carracedo, et al.
Genes (2020) Vol. 11, Iss. 11, pp. 1376-1376
Open Access | Times Cited: 27
Overlaps, gaps, and complexities of mouse models of Developmental and Epileptic Encephalopathy
Wanqi Wang, Wayne N. Frankel
Neurobiology of Disease (2020) Vol. 148, pp. 105220-105220
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top